Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Mycobacterium tuberculosis allergen ESAT6-CFP10 Phase III Trial in Healthy Adults
ChiCTR-IIR-16007904Phase 3Not yet recruiting
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of C-Tb in Tuberculosis (TB) (2 arms), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Planned start Feb 2016; status: not yet recruiting.
02
Drugs
C-Tb
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR-IIR-16007904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16007904.